“tC19Z, synthesised in Phil Holliger’s lab at LMB, could be a version of one of the first enzymes that ever existed on our planet – and a clue to how life itself got started.” More…
LMB In The News
Heptares Therapeutics helps push GPCR drug discovery forward
“G-protein-coupled receptors are hot drug targets, and plenty of companies want to know what they look like to get an edge on making new drugs. Despite recent advances, getting X-ray crystal structures for GPCRs is still far from easy. Heptares Therapeutics, joins a trio of firms in licensing their structure-determining technology and partnering with large […]
Max Perutz: his life and legacy
“LMB scientists take part in a round-table discussion about Max Perutz.” More…
Mariann Bienz talks about signalling pathways as a target for cancer therapies
“A number of signalling pathways discovered in Drosophila flies and other model organisms have subsequently turned out to be important in cancer and specifically in cancer stem cell function. Mariann Bienz talks about the role of the Wnt signalling pathway in cancer growth and cancer metastases but warns of difficulties developing therapies to target this […]
Light turns on caged enzyme
“An unnatural amino acid has given researchers a switch to turn on a specific enzyme with light. This tool will allow scientists to determine the timing of cellular signaling and identify which parts of a signaling network might be good drug targets. When organisms or cells receive signals from their surroundings, a cascade of enzymes […]
Greg Winter presented with Distinguished Technopreneur Speaker Award
“The Distinguished Technopreneur Speaker (DTS) Forum, organised by Exploit Technologies, serves as a relevant platform for entrepreneurs, industry leaders, researchers, scholars and students to converge, share ideas and network with various industry players to seed the spirit of innovation and entrepreneurship amongst the local scientific community. This year’s Distinguished Technopreneur Speaker Award recipient is serial […]